GOLDMAN SACHS GROUP INC - ACORDA THERAPEUTICS INC ownership

ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 185 filers reported holding ACORDA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.07 and the average weighting 0.0%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ACORDA THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$36,000
-66.0%
70,010
-51.3%
0.00%
Q2 2020$106,000
-68.9%
143,748
-60.7%
0.00%
Q1 2020$341,000
-50.2%
365,811
+8.9%
0.00%
Q4 2019$685,000
-35.9%
335,819
-9.8%
0.00%
Q3 2019$1,068,000
-74.8%
372,281
-32.7%
0.00%
-100.0%
Q2 2019$4,242,000
-53.1%
553,075
-18.7%
0.00%
-66.7%
Q1 2019$9,044,000
-20.4%
680,564
-6.7%
0.00%
-25.0%
Q4 2018$11,360,000
-14.4%
729,083
+8.0%
0.00%
+33.3%
Q3 2018$13,268,000
-31.7%
675,212
-0.2%
0.00%
-40.0%
Q2 2018$19,425,000
+49.0%
676,810
+22.8%
0.01%
+66.7%
Q1 2018$13,037,000
+22.2%
551,247
+10.9%
0.00%
+50.0%
Q4 2017$10,667,000
-21.2%
497,287
-13.1%
0.00%
-33.3%
Q3 2017$13,535,000
+28.4%
572,316
+7.0%
0.00%0.0%
Q2 2017$10,538,000
+5.9%
534,956
+12.9%
0.00%0.0%
Q1 2017$9,951,000
+53.7%
473,889
+37.6%
0.00%
+50.0%
Q4 2016$6,475,000
-57.2%
344,397
-52.5%
0.00%
-60.0%
Q3 2016$15,133,000
+102.7%
724,772
+147.7%
0.01%
+150.0%
Q2 2016$7,464,000
-26.6%
292,626
-23.9%
0.00%
-33.3%
Q1 2016$10,174,000
-56.3%
384,680
-29.3%
0.00%
-62.5%
Q4 2015$23,274,000
+103.7%
544,042
+26.2%
0.01%
+100.0%
Q3 2015$11,425,000
-8.7%
430,974
+14.8%
0.00%
+33.3%
Q2 2015$12,517,000
+43.0%
375,557
+42.8%
0.00%0.0%
Q1 2015$8,751,000
-9.5%
262,958
+11.2%
0.00%0.0%
Q4 2014$9,665,000
-33.1%
236,490
-44.5%
0.00%
-40.0%
Q3 2014$14,441,000
+46.0%
426,271
+45.3%
0.01%
+66.7%
Q2 2014$9,892,000
-77.4%
293,436
-74.6%
0.00%
-78.6%
Q1 2014$43,802,000
+0.5%
1,155,415
-22.6%
0.01%0.0%
Q4 2013$43,603,000
+18.2%
1,493,239
+38.5%
0.01%0.0%
Q3 2013$36,883,000
+37.7%
1,078,446
+32.8%
0.01%
+27.3%
Q2 2013$26,788,000
+257.9%
811,997
+169.7%
0.01%
+266.7%
Q4 2012$7,485,000
+25.6%
301,109
+29.4%
0.00%
+50.0%
Q3 2012$5,960,000
+177.9%
232,708
+155.6%
0.00%
+100.0%
Q2 2012$2,145,000
+100.7%
91,050
+126.2%
0.00%
Q1 2012$1,069,00040,2510.00%
Other shareholders
ACORDA THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
Sio Capital Management, LLC 1,045,400$21,953,00012.28%
SCOPIA CAPITAL MANAGEMENT LP 5,568,306$116,934,0002.16%
GREAT POINT PARTNERS LLC 432,500$9,083,0001.80%
Consonance Capital Management LP 619,419$13,008,0001.36%
RA Capital Management 489,828$10,286,0001.26%
Ghost Tree Capital, LLC 300,000$6,300,0001.17%
DLD Asset Management, LP 281,900$5,920,0000.95%
DLD Asset Management, LP 281,900$5,914,0000.95%
Worth Venture Partners, LLC 36,650$770,0000.68%
Malaga Cove Capital, LLC 51,013$939,0000.57%
View complete list of ACORDA THERAPEUTICS INC shareholders